Skip to Content

Cancer Epigenomics Improve the Overall Survival and the Quality of Life

Marc Eid and Karl Semaan from Dana-Farber Cancer Institute present in this MEDtalk their work on the non-invasive detection of aggressive variants of renal cell carcinoma and prostate cancer using epigenomic liquid biopsy.

Marc Eid og Karl Semaan

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top